Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group Article

Lin, Nancy U, Wefel, Jeff Rey S, Lee, Eudocia Q et al. (2013). Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group . LANCET ONCOLOGY, 14(10), E407-E416. 10.1016/S1470-2045(13)70308-5

International Collaboration

cited authors

  • Lin, Nancy U; Wefel, Jeff Rey S; Lee, Eudocia Q; Schiff, David; van den Bent, Martin J; Soffietti, Riccardo; Suh, John H; Vogelbaum, Michael A; Mehta, Minesh P; Dancey, Janet; Linskey, Mark E; Camidge, D Ross; Aoyama, Hidefumi; Brown, Paul D; Chang, Susan M; Kalkanis, Steven N; Barani, Igor J; Baumert, Brigitta G; Gaspar, Laurie E; Hodi, F Stephen; Macdonald, David R; Wen, Patrick Y

sustainable development goals

authors

publication date

  • September 1, 2013

published in

keywords

  • BREAST-CANCER
  • CELL LUNG-CANCER
  • Life Sciences & Biomedicine
  • MOTEXAFIN GADOLINIUM
  • Oncology
  • PHASE-III TRIAL
  • PROPHYLACTIC CRANIAL IRRADIATION
  • RADIATION-THERAPY
  • RANDOMIZED-TRIAL
  • SINGLE METASTASES
  • STEREOTACTIC RADIOSURGERY
  • SURGICAL RESECTION
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • E407

end page

  • E416

volume

  • 14

issue

  • 10